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Abstract: Clinicians have an increasing number of evidence-based interventions to treat pain in 
youth. Mediation analysis offers a way of investigating how interventions work, by examining the 
extent to which an intermediate variable, or mediator, explains the effect of an intervention. This 
systematic review examined studies that used mediation analysis to investigate mechanisms of in-
terventions on pain-relevant outcomes for youth (3–18 years) with acute or chronic pain, and pro-
vides recommendations for future mediation research in this field. We searched five electronic da-
tabases for clinical trials or observational longitudinal studies that included a comparison group 
and conducted mediation analyses of interventions on youth and assessed pain outcomes. We 
found six studies (N = 635), which included a total of 53 mediation models examining how inter-
ventions affect pain-relevant outcomes for youth. Five studies were secondary analyses of random-
ized controlled trials of psychological interventions for chronic pain; one was a longitudinal obser-
vational study of morphine for acute pain. The pain conditions studied were irritable bowel syn-
drome, functional abdominal pain, juvenile fibromyalgia, mixed chronic pain, and post-operative 
pain. Fourteen putative mediators were tested, of which three partially mediated treatment effect; 
seven did not significantly mediate treatment effect and four had mixed results. Methodological 
and reporting limitations were common. There are substantial gaps in the field with respect to in-
vestigating, and therefore understanding, how paediatric interventions work. 
Keywords: pain; mediation analysis; paediatric; chronic pain; acute pain 
 
1. Introduction 
Pain is common in childhood and adolescence [1,2], presenting after an injury or pro-
cedure, as a consequence of disease, or without any identifiable cause [3]. Effective inter-
ventions for acute and chronic pain in young people are critically needed. Many interven-
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tions encompass a variety of single and multi-modal treatments including pharmacologi-
cal, psychological, and physical interventions. The efficacy of such treatments for children 
and adolescents with acute pain and chronic has been reviewed (e.g., [4–7]). Some seem 
effective, but effect sizes are small. One potential explanation is that small effect sizes may 
represent wide variability in patient response, which could be addressed by better under-
standing the underlying mechanisms of treatment effects. For example, acceptance and 
commitment therapy (ACT) is thought to operate via the proposed mechanism of chang-
ing psychological flexibility [8], and cognitive behavioural therapy (CBT) is thought to 
operate by changing maladaptive cognitions (e.g., pain catastrophizing) [9]. Understand-
ing treatment mechanisms would allow targets for paediatric pain interventions to be in-
formed by empirical evidence, rather than presumptive theories. Clinicians would there-
fore be able to refine and optimize the effectiveness of interventions by selectively target-
ing mechanisms known to improve outcomes [10]. 
Mediation analysis is the most frequently used quantitative method for evaluating 
the mechanisms of interventions [11]. Mediation analyses answer questions about how or 
why an intervention works, or does not work, by estimating the extent to which interven-
tions exert their effects on outcomes via mediating variables (i.e., ‘mediators’). For exam-
ple, in a recent mediation analysis, Kendall, et al. [12] showed that cognitive-behavioural 
therapy (termed the ‘exposure’) reduced anxiety symptoms (termed the ‘outcome’) in 
youth through improvements in coping efficacy but not through reductions in anxious 
self-talk. Mediation analyses targeting how or why an intervention works require longi-
tudinal data because the timing of effects between the treatment, mediator and outcome, 
needs to be established. These analyses also require comparison groups for the interven-
tion because a causal contrast against the treatment cannot be evaluated without one 
[11,13]. For the purpose of making causal inferences, mediation analyses are best con-
ducted on randomized designs that eliminate potential confounding of the intervention-
mediator effects, but non-randomized designs are acceptable if potential confounders are 
controlled for. 
Mediation analyses that examine potential mediators of interventions for paediatric 
pain exist, but a systematic evaluation of the field is lacking. Systematic reviews of medi-
ation analyses have examined potential mediators of interventions for adults with mus-
culoskeletal pain [14] and back pain [15], but whether we can generalize these findings to 
children and adolescents with pain, who are developmentally unique and the interven-
tions are modified accordingly, remains unknown. Some mechanisms are common to pae-
diatric acute and chronic pain conditions; others are not [16]. Little is known if the same 
principle applies to treatment. This review aimed to systematically identify, summarize, 
and critically appraise studies that use appropriate mediation analysis to examine poten-
tial mediators of the effect of any intervention on pain-relevant outcomes for children (3–
12 years) and adolescents (13–18 years) with acute or chronic pain. 
2. Materials and Methods 
2.1. Study Design and Registration 
This systematic review followed a pre-defined protocol that was prospectively regis-
tered on PROSPERO (CRD42020160743) and the Open Science Framework 
(https://osf.io/pw7yb/). Deviations from the pre-registered protocol are explained in the fol-
lowing section (also listed in Supplementary Table S1). Reporting is according to the Pre-
ferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines 
[17]. 
2.2. Search Strategy 
2.2.1. Database Search 
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The following electronic databases were searched from their inception up to 4 Janu-
ary 2021: EMBASE (OvidSP), Medline (OvidSP), Emcare (OvidSP), PsycINFO (OvidSP), 
and Cochrane Central Register of Controlled Trials (CENTRAL). A MEDLINE search 
strategy was developed in conjunction with a medical librarian and was adapted for other 
databases (see Supplementary Table S2 for complete search strategy). We combined three 
sets of descriptors to capture: (1) paediatric populations (e.g., child, adolescent), (2) pain 
conditions, (3) mediation analysis (e.g., causal pathway, indirect effect). To ensure we cap-
tured all pain conditions, we included broad search terms for pain, as well as specific 
terms for chronic pain conditions common to paediatric populations [2] (e.g., irritable 
bowel syndrome, migraine, fibromyalgia). Specific search terms were altered for individ-
ual electronic databases (e.g., MeSH). To provide a comprehensive review of the literature, 
no time or language limits were applied to any of the databases; however, searches were 
limited to human participants only. The systematic search was conducted by a single in-
vestigator (H.B.L.). 
2.2.2. Other Sources 
Potentially relevant unpublished literature was captured by contacting authors of 
abstracts identified in the electronic database search as conference proceedings, disserta-
tions, or on ClinicalTrials.gov. Reference lists of relevant systematic reviews [4–7] and of 
all studies for which full text articles were retrieved were manually searched for addi-
tional studies. 
2.3. Eligibility Criteria 
To be included, studies had to: 1) be published, peer-reviewed reports; 2) have en-
rolled a sample of children and adolescents aged 3 to 18 years (referred to hereafter as 
‘youth’), with pain at baseline of any condition and duration; 3) have investigated any 
therapeutic intervention delivered in-person or via technology; 4) be a clinical trial (in-
cluding randomized and non-randomized designs) or an observational longitudinal 
study; 5) have included any comparator/control group(s); 6) have conducted mediation 
analysis to investigate the role of one or more mediator(s) in explaining the pathway from 
an intervention for paediatric pain to a pain-related outcome; 7) have assessed an outcome 
from the PedIMMPACT recommendations for paediatric pain core outcome domains for 
acute (e.g., pain intensity, physical recovery), chronic or recurrent pain (e.g., symptoms, 
emotional functioning) [18]; 8) have included any number of participants (i.e., no limit on 
sample size); and 9) be reported in English, Portuguese, Spanish, or German (translators 
were available for only these languages). Studies were excluded if: 1) the independent 
variable in the mediation analysis was not the intervention, 2) ≥ 25% of the sample were 
adults (to ensure majority of sample were youth, while accommodating differing defini-
tions of developmental stages), or 3) ≥ 20% of participants did not report any pain at base-
line (to account for pain conditions that present episodically). 
2.4. Study Selection 
Studies identified by the systematic search were exported to Endnote (Clarivate An-
alytics, Philadelphia, USA) and duplicates were removed. The studies were then up-
loaded to Covidence (Covidence.org) for screening. A two-stage screening process was 
used to identify relevant studies. In the first stage, titles and abstracts of each of the re-
trieved studies were independently screened by two of three reviewers (H.B.L., J.W.P., 
M.A.W.). To account for the possibility that eligible records did not mention mediation 
analysis (or related terms) in the title or abstract, in stage one the reviewers included rec-
ords that appeared to fit inclusion criteria 1–5 (see Eligibility Criteria). Studies that were 
clearly irrelevant were excluded. Full texts of remaining studies were retrieved. In stage 
two, the full texts of all potentially eligible articles were screened for inclusion by two 
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independent reviewers (H.B.L., M.A.W.) against the full eligibility criteria. At each stage, 
disagreements were resolved by a third reviewer (H.L.). 
2.5. Data Extraction 
Data were extracted in duplicate by two reviewers (H.B.L., M.A.W.) using a custom-
ized, piloted data extraction form. A third reviewer was consulted for unresolved disa-
greements (H.L.). The following data were extracted: study characteristics (e.g., setting, 
study design); participants (e.g., number, age, gender, pain condition, pain duration); in-
tervention, mediator, and outcome variables (construct, measurement tool, time of meas-
urement); mediation analysis method; measures taken to control for confounders; testing 
of moderated mediation paths; effect sizes, point estimates and 95% confidence intervals 
(CIs) of path a, path b, total, direct and indirect effects, proportion mediated; and the au-
thors’ conclusion(s). We also considered the type of mediation analysis used, as one of 
two broad categories [19]—(a) the traditional statistical methods that use Baron and 
Kenny’s framework, the difference and product of coefficients approach [20] or (b) the 
modern and flexible counterfactual (or potential outcomes) approaches that use simula-
tion based methods [21]. 
2.6. Outcomes 
We included studies that directly assessed, or used a composite outcome assessment 
that includes, one or more of the recommendations for paediatric pain core outcomes for 
acute, chronic or recurrent pain (PedIMMPACT) [18]. These outcomes include pain inten-
sity, global judgment of satisfaction with treatment, symptoms and adverse events, phys-
ical recovery, physical functioning, emotional response, emotional functioning, economic 
factors, role functioning, and sleep. It is recommended to use child-report as primary as 
most children above the age of 8 years can provide a valid self-report [22,23]—if parent, 
physician, and child reports for the same outcome were provided, and ≥ 80% of the sample 
were 8 years or older, only the child-reported outcome was included in the manuscript 
(the parent- or clinician-report was included in Supplementary Materials). 
2.7. Quality Assessment 
Mediation studies meeting the inclusion criteria were assessed for methodological 
quality using a bespoke appraisal tool. The bespoke appraisal tool was adapted from rec-
ommendations for mediation analyses by Vo, et al. [24], which includes items on planning 
(e.g., protocol registration, sample size estimation), conduct (e.g., handling missing data, 
adjustment for confounding variables) and reporting (e.g., use of causal diagram, report-
ing point estimates and confidence intervals). The recommendations of Vo, et al. [24] were 
designed for controlled trials (RCTs) and needed to be adapted for use with non-random-
ized designs that require additional adjustment of confounders. Confounders are varia-
bles that could induce a spurious (non-causal) association between intervention (usually 
called ‘exposure’ in mediation analyses) and mediator (path a), mediator and outcome 
(path b), or intervention and outcome (path c) (see Figure 1) [15]. When an intervention is 
randomised (e.g., in an RCT) the intervention-mediator and intervention-outcome effects 
can be considered unconfounded and adjustment only needs to be made for potential 
confounders of mediator-outcome effects. However, when the intervention is not 
randomised (e.g., in non-randomized designs) it is necessary to control for all possible 
confounders of effects (i.e., path a, path b, path c). Therefore, when the appraisal tool was 
used to assess the quality of non-randomized designs, we adapted two items (items 1.3 
and 2.5) so that adjustment of intervention-mediator and intervention-outcome confound-
ers would be considered. We also operationalised item 3.7 such that this item assessed if 
studies discussed the validity of the following causal assumptions: temporal ordering and 
no unmeasured confounding [21]. We acknowledge that the validity of other causal as-
sumptions could have been assessed here (e.g., positivity, consistency) but have not. Two 
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reviewers independently appraised the methodological quality of the studies (H.B.L., 
M.A.W.); disagreements between the two reviewers were resolved via discussion, or a 
third reviewer (H.L.). Use of bespoke appraisal tool is a deviation from the protocol, as 
the recommendations by Vo, et al. [24] were published after protocol pre-registration. 
 
Figure 1. Single mediator model. 
2.8. Data Synthesis 
We considered youth across developmental stages, including children (3–12 years) 
and adolescents (13–18 years). Where possible, we aimed to interpret the results according 
to these subgroups, although we acknowledge that a 17-year-old may indeed be more 
similar to an adult than to a 13-year-old. In this review, we included any intervention but 
reported results according to intervention type (e.g., psychological, pharmacological). 
Heterogeneity in pain condition, intervention, mediators, and outcomes precluded meta-
analysis, so data were qualitatively synthesized in accordance with the Synthesis Without 
Meta-analysis (SWiM) reporting guidelines [25]. Narrative analysis included a description 
of author(s), year of publication, country, study design, population, sample size, interven-
tion type and duration, outcome measures, and schedule of outcome assessments. Studies 
were grouped based on duration of pain, either as acute pain (duration less than 3 months) 
or chronic pain (duration of three months or longer [26]). This grouping was a deviation 
from our initial protocol and reflects our consideration that the mechanisms of treatment 
effect may depend on pain duration. Tables are also ordered in relation to clinical popu-
lation (i.e., similar conditions are presented together). 
Where possible, outcomes were reported for each model including point estimate, 
confidence interval and significance levels of path a, path b, total effect, direct effect, indi-
rect effect, and proportion mediated. In this review, an indirect effect was reported as 
significant if the 95% confidence interval did not include 0. To assist with comparison 
between outcomes, data were transformed to present standardized regression coefficients 
and 95% CIs where possible. In studies where a 90% confidence interval was reported, 
this was transformed to a 95% confidence interval using the reported standard error. In 
studies that reported unstandardized correlation coefficients, these were transformed to 
standardized coefficients (calculation 2.3 in [27]). In studies that used a product of coeffi-
cient approach [20] but did not report a correlation coefficient for the indirect effect, this 
was calculated by multiplying the coefficients of path a and path b [11]. 
3. Results 
3.1. Study Selection 
The search strategy identified 7334 records for consideration, of which 187 potentially 
relevant full-text articles were retrieved and screened to determine eligibility. The main 
reason for exclusion at full-text screening was due to irrelevant study design; full details 
of reasons for exclusion are provided in Supplementary Table S3. Six articles met the in-
clusion criteria and were included for review (Figure 2). 
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3.2. Characteristics of the Included Studies 
Six included studies (comprising 635 participants) were undertaken in USA (n = 3) 
and Sweden (n = 3) and published between 2011 and 2020. Sample sizes at baseline ranged 
from 30 to 200 participants. One study included only children (i.e., 8–12 years); one study 
included only adolescents (i.e., 13–17 years); four studies included children and adoles-
cents (e.g., 7–17 years [28]). Most (72.9%) participants were female. Five studies included 
participants with chronic pain, one study included participants with acute pain. Five stud-
ies were secondary analyses of previously published RCTs; one study was a prospective, 
non-randomized, observational study. All studies used a statistical analytic approach to 
mediation analyses [20]. Five studies analysed the product of coefficients and one study 
conducted structural equation modelling. Table 1 provides a summary of the characteris-
tics of each study. Two included studies [28,29] reported results of mediation analyses 
using both child- and parent-reported outcomes. We describe the results of mediation 
analyses using child-reported outcomes. Results using parent-reported outcomes are pro-
vided in Supplementary Tables S4 and S5. 
 
Figure 2. PRISMA flow diagram of the record selection process. 
3.3. Methodological Quality 
The individual study quality assessments are presented in Table 2, with justification 
provided in Supplementary Table S6. Across six studies, 53 mediation models were tested. 
All models performed well in a few domains of methodological quality for mediation 
studies. In all 53 models, the choice of mediator was based on clinical rationale, and the 
mediator was assessed prior to the outcome. All studies used an appropriate framework 
for analysis—either the product of coefficient approach (35/53) or structural equation 
modelling (18/53)—and report their approach. 
Frequently, models were inconsistent in their engagement with quality domains. 
Four mediation models reported that they were prospectively planned. Causal diagrams 
were reported to outline 23/53 mediation models. One model analysed non-randomized 
data and controlled for intervention-mediator (path a) confounders; an adjustment that 
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was not required for the remaining 52 models that analysed randomized data. However, 
only 21/53 models adjusted for mediator-outcome (path b) confounders. Most models 
(44/53) included additional analyses to justify the validity of the assumption of temporal 
ordering.  
In some key domains of quality for mediation analysis, studies performed poorly. No 
power calculations were planned or reported for any model. Only two of the models in-
cluded potential interactions (i.e., moderators) in analysis, but none evaluated and re-
ported goodness-of-fit indices. Justification for the plausibility of the assumption of no 
unmeasured confounding was not provided for any models, and no sensitivity analyses 
were conducted to test this assumption. 
3.4. Models and Mediators Tested 
Across the six included studies, the number of mediation models tested ranged from 
1 to 24, amounting to a total of 53 mediation models (Table 1). The number of mediation 
models tested per study varied as each study assessed differing numbers of putative me-
diators, outcomes, and time-points of outcome assessment. For example, Lalouni, et al. 
[29] tested two models assessing the effect of two putative mediators on one outcome 
measured at one time point; whereas Wicksell, et al. [30] tested 24 models assessing the 
effect of six putative mediators on two outcomes measured at two time points (detailed 
results in Supplementary Table S7). Of the 53 mediation models that were tested, 12 mod-
els found variables that significantly mediated treatment effects, and 41 models assessed 
variables that did not mediate treatment effects. 
In total, 14 putative mediators were assessed in the 53 mediation models. Three me-
diators were found to significantly mediate treatment effect (morphine consumption, GI-
specific avoidance behaviour, GI-specific anxiety), seven did not significantly mediate 
treatment effect (perceived stress, solicitousness, pain coping, coping efficacy, self-effi-
cacy, kinesophobia, pain intensity) and four had mixed results (perceived pain threat, pain 
catastrophizing, pain impairment beliefs, pain reactivity). A summary of results of medi-
ation analysis are provided in Table 3; detailed results are provided in Supplementary 
Table S7. 
3.5. Mediators of Interventions for Acute Pain 
One study analysed data from a non-randomized observational design, that investi-
gated an intervention for acute pain in children and adolescents (10–18 years) after spinal 
surgery [31]. One mediation model was analysed, that explored the mechanism of peri-
operative intravenous (IV) acetaminophen compared to no IV acetaminophen, on hospital 
length of stay. A statistical mediation analysis using a product of coefficient approach [20] 
of complete cases (n=114) indicated that 79% of the intervention effect was mediated by a 
decrease in post-operative morphine consumption (indirect effect = −0.31; Sobel’s test: p = 
0.013). 
3.6. Mediators of Interventions for Chronic Pain 
Five studies analysed 52 mediation models of interventions for youth with chronic 
pain. All studies performed secondary analyses of data from RCTs and all investigated 
mechanisms of psychological interventions. A variety of pain conditions were studied, 
including gastro-intestinal (GI)-related pain (irritable bowel syndrome [IBS], functional 
abdominal pain) [28,29,32], and non-GI related pain (mixed chronic pain, fibromyalgia) 
[30,33]. A summary is provided below, and available detailed results of each model are 
provided in Supplementary Table S7. 
3.6.1. GI-Related Chronic Pain 
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GI-specific avoidance behaviour mediated 67% of the treatment effect of internet-de-
livered CBT compared to waitlist control (n = 101) at reducing GI symptoms for adoles-
cents (13-17 years) with IBS (indirect effect = −0.37 [95% CI, −0.09, −0.62]) [32]. In another 
study, GI-specific avoidance behaviour also mediated treatment effect of internet-deliv-
ered CBT compared to treatment as usual (n = 90) at reducing GI symptoms for children 
(8–12 years) with FAPD (indirect effect = −1.73 [0.48, 3.64]) [29]. 
GI-specific anxiety mediated the treatment effect of internet-delivered CBT com-
pared to treatment as usual (n = 90) at reducing GI symptoms for children (8–12 years) 
with functional abdominal pain disorder (indirect effect = 2.23 [0.66, 4.37]) [29].  
Perceived pain threat mediated the intervention effect of social-learning CBT on re-
ducing pain intensity at 3-months (indirect effect = −0.11 [−0.18, −0.03]) and 6-months post-
treatment (indirect effect = −0.07 [−0.13, −0.003]) for children and adolescents (7–17 years) 
with FAPD [28]. However, in the same study, perceived pain threat did not mediate the 
treatment effect on reducing pain intensity at 12-months; nor did perceived pain threat 
mediate the treatment effect on reducing GI symptom severity at 3-, 6-, or 12 months [28]. 
Pain catastrophizing mediated the treatment effect of social-learning CBT at reducing 
GI symptom severity at 3-months (indirect effect = −0.02 [−0.03, −0.001]). However, in the 
same study, pain catastrophising did not mediate the treatment effect on reducing GI-
symptom severity at 6- or 12- months; nor did pain catastrophizing mediate the treatment 
effect on reducing pain intensity at 3-, 6-, or 12 months [28]. 
Perceived stress did not significantly mediate the treatment effect of internet-deliv-
ered CBT compared to a waitlist control (n = 101) for adolescents (13–17 years) with IBS 
(indirect effect = 0.002 [95% CI, −0.08, 0.09]) [32]. 
Parent solicitousness did not significantly mediate the treatment effect of social-
learning CBT (i.e., children learning through social observation of parent behaviour) com-
pared to education on either of two outcomes (GI symptom severity, pain intensity) for 
children and adolescents (7–17 years) with FAPD, at any of the three measured time points 
(3-, 6-, and 12-months post treatment) [28].  
Parent-reported outcomes: Perceived pain threat, pain catastrophizing, parent solic-
itousness, GI-specific avoidance behaviour and GI-specific anxiety were also evaluated as 
mediators of treatment effect on outcomes that were parent-reported. Findings were 
largely similar to those of child-reported outcomes (see Supplementary Table S4, S5). 
3.6.2. Non-GI-Related Chronic Pain 
Pain reactivity mediated the treatment effect of acceptance and commitment therapy 
(ACT) compared to a multidisciplinary treatment approach with amitriptyline (n = 30) for 
children and adolescents (10–18 years) with mixed chronic pain conditions, at reducing 
pain interference at 3.5-months (indirect effect = 0.03 [unstandardized coefficient = 1.10; 
95% CI = 0.08, 3.01]) and 7-months (indirect effect = 0.04 [unstandardized coefficient = 1.69; 
95% CI = 0.17, 4.32]) and depression at 3.5 months (indirect effect = 0.04 [unstandardized 
coefficient = 5.43; 95% CI = 0.01, 14.77]). However, in the same study, pain reactivity did 
not mediate the treatment effect on reducing depression at 7 months [30]. 
Pain impairment beliefs mediated the treatment effect of ACT compared to a multi-
disciplinary treatment approach with amitriptyline (n = 30) for children and adolescents 
(10–18 years) with mixed chronic pain conditions, at reducing depression at 3.5-months 
(indirect effect = 0.05 [unstandardized coefficient = 1.75; 95% CI = 1.75, 14.59]) and 7-
months (indirect effect = 0.07 [unstandardized coefficient = 11.56; 95% CI= 2.46, 26.55]). 
However, in the same study, pain impairment beliefs did not mediate the treatment effect 
on reducing pain interference at 3.5- or 7-months [30]. 
Pain catastrophizing did not mediate the treatment effect of CBT compared to fi-
bromyalgia education (n = 100) at reducing either of two outcomes (functional disability, 
depression) at 6-months post-treatment for children and adolescents (11–18 years) with 
juvenile fibromyalgia [33]. In another study, pain catastrophizing also did not mediate the 
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treatment effect of ACT compared to a multidisciplinary treatment approach with ami-
triptyline (n = 30) for children and adolescents (10–18 years) with mixed chronic pain con-
ditions, on either of two outcomes (pain interference, depression) at any measured time-
point (3.5- and 7-months post-treatment) [30]. 
Pain coping and coping efficacy did not mediate the treatment effect of CBT com-
pared to fibromyalgia education (n=100) at reducing either of two outcomes (functional 
disability, depression) at 6 months post-treatment for children and adolescents (11–18 
years) with juvenile fibromyalgia [33]. 
Self-efficacy, kinesiophobia, and pain intensity did not mediate the treatment effect 
of ACT compared to a multidisciplinary treatment approach with amitriptyline (n = 30) 
for children and adolescents (10–18 years) with mixed chronic pain conditions, on either 
of two outcomes (pain interference, depression) at any measured time-point (3.5- and 7-
months post-treatment) [30]. 
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Table 1. Summary of characteristics of included studies 
Study Design Sample 
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USA, n = 114 [78 
female (68%), age 
14.4 (SD = 2.0) 
Acute pain/ Post pos-
terior spinal fusion 
for idiopathic scolio-
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minophen (n = 70) 
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Chronic pain/ IBS 
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ternet-CBT (n = 47) 










M & O: weekly 
during treat-
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Product of coefficients 
[20,35] with boot-
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ACT (n = 15) 
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* = child report; † = parent report; ACT, Acceptance and Commitment Therapy; ARCS, Adult Responses to Children’s Symptoms; BRQ-C, Irritable Bowel Syndrome 
Behavioral Responses Questionnaire – Child; CES-DC, Centre for Epidemiological Studies Depression Scale for Children; CDI, Children’s Depression Inventory; CBT, 
Cognitive Behavioral Therapy; CI, confidence interval; CSI, Children’s Somatization Inventory; FDI, Functional Disability Inventory; FPS-R, Faces Pain Scale – Revised; 
GSRS-IBS, Gastrointestinal Symptom Rating Scale – Irritable Bowel Syndrome; IBS, Irritable Bowel Syndrome; IBS-BRQ, IBS-specific Behavioral Response Questionnaire; 
MDT, Multi-Disciplinary Therapy; PBQ, Pain Beliefs Questionnaire; PCQ, Pain Coping Questionnaire; PedQL-GI, Pediatric Quality of Life Gastrointestinal symptoms scale; 
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PPII, Pain Interference Index; PAIRS, Pain and Impairment Relationship Scale; PRI, Pain Response Inventory; PRS, Pain Reactivity Scale; PSS-10, Perceived Stress Scale-10; 
RCT, Randomized Controlled Trial; SES, Self-Efficacy Scale; TSK, Tampa Scale of Kinesiophobia; VAS, Visual Analogue Scale; VSI-C, Visceral Sensitivity Index for Children.
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Table 2. Quality assessment in included studies 
1. Planning Olbrecht, et al. 
[31] 
Bonnert, et al. 
[32] 
Lalouni, et al. 
[29] 
Levy, et al. 
[28] 
Kashikar-Zuck, 
et al. [33] 
Wicksell, et al. 
[30] 
1.1. Was the mediation analyses planned a priori in the trial 
protocol? 
      
1.2.1. Was the choice of mediators based on clinical ra-
tionale underlying the mechanisms through which the 
treatment affects the outcome? 
      
1.2.2. Was the choice of mediators based on independent 
data? 
      
1.3.1. Was there a plan to collect pre- and post-randomiza-
tion confounders of the exposure-mediator relationship?  
 n/a n/a n/a n/a n/a 
1.3.2. Was there a plan to collect pre- and post-randomiza-
tion confounders of the mediator-mediator relationship? 
n/a      
1.3.3. Was there a plan to collect pre- and post-randomiza-
tion confounders of the mediator-outcome relationship? 
      
1.4.1. Were the mediators measured prior to the outcome to 
assure the causal interpretation of the findings? 
      
1.4.2. Was the mediator(s) measured repeatedly?       
1.5. Was a causal diagram reported, underlying the causal 
relationship of the treatment, mediator(s) and outcome? 
      
1.6. Was the sample size for the mediation analysis esti-
mated? 
      
1.7. Was the conduct of a mediation analysis dependent on 
whether a statistically significant intention-to-treat treat-
ment effect was found? 
? ?  ? ? ? ? 
‘Planning’ domain summary score 5/ 10 6/10 6/10 4/10 3/10 3/10 
2. Conduct 
2.1.1 Was multiple imputation (or other valid approaches) 
used to handle missing data? 
    n/a  
2.1.2 If a complete-case analysis was used, did they adjust 
for baseline covariates that were differentially distributed 
between responders and non-responders?  
 n/a n/a n/a n/a ? 
2.1.3 Was a sensitivity analysis conducted to assess the im-
pact of different approaches on the findings? 
    n/a  
2.2 Does the study report separate analyses for separate 
mediators? 
n/a      
2.3 Does the study use an appropriate framework for anal-
ysis? 
      
2.4.1 Does the study evaluate the goodness-of-fit of each 
model? 
      
2.4.2 Does the study assess potential interaction(s) between 
treatment and confounding factors, treatment and media-
tor, mediator and mediator in the mediator and outcome 
models?  
      
2.5.1a Does the study adjust for exposure-mediator and 
confounders? 
 n/a  n/a n/a n/a n/a 
2.5.2 Does the study adjust for mediator-mediator con-
founders? 
n/a      
2.5.3 Does the study adjust for mediator-outcome con-
founders? 
      
2.6.1 Does the study perform sensitivity analysis to assess 
sensitivity of the results to the assumption of no measured 
mediator-mediator or mediator-outcome confounder? 
      
2.6.2 Does the study perform sensitivity analysis to assess 
sensitivity of the results to potential measurement errors of 
the mediators? 
      
2.7 Does the study use apt strategies when some of the me-
diator-mediator or mediator-outcome confounders are po-
tentially affected by the treatment (e.g., by considering con-
founders as mediators themselves)? 
      
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‘Conduct’ domain summary score 5/11 4/11 3/11 4/11 2/9 2/12 
3. Reporting 
3.1.1. Does the study report the approaches used for media-
tion analysis? 
      
3.1.2. Does the study provide a causal diagram that under-
lies the analysis? 
      
3.2.1. Does the study report the sample size calculation?       
3.2.2. Does the study report the actual sample size of the 
mediation analysis? 
      
3.2.3. Does the study report how missing data is handled?     n/a  
3.3. Does the study report all confounders considered and 
adjusted for in the analysis? 
      
3.4.1. Does the study report the model building procedure 
and the final form of all models used in the analysis? 
      
3.4.2. Does the study report the goodness-of-fit of the mod-
els? 
      
3.5. Does the study report the point estimates and the con-
fidence intervals of the different direct, indirect and total 
treatment effects? 
      
3.6. Does the study report the methods and results of all 
sensitivity and other additional analyses (in the main paper 
or appendices)? 
n/a  n/a n/a n/a  
3.7. Does the study discuss the validity of all causal as-
sumptions underlying the analysis (in the main paper or 
appendices)? 
      
‘Reporting’ domain summary score 5/10 5/11 5/10 5/10 2/9 3/11 
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vs no intravenous acetamino-
phen 








+ GI symptoms + 








+ GI symptoms + 
+ GI-specific anxiety + GI symptoms + 
Levy, et al. 
[28] 
SLCBT vs education 
+ Perceived pain threat – GI symptom severity at 3 months – 
+ Perceived pain threat – GI symptom severity at 6 months – 
+ Perceived pain threat – GI symptom severity at 12 months – 
+ Perceived pain threat + Pain intensity at 3 months + 
+ Perceived pain threat + Pain intensity at 6 months + 
+ Perceived pain threat – Pain intensity at 12 months – 
+ Solicitousness – GI symptom severity at 3 months – 
+ Solicitousness – GI symptom severity at 6 months – 
+ Solicitousness – GI symptom severity at 12 months – 
+ Solicitousness – Pain intensity at 3 months – 
+ Solicitousness – Pain intensity at 6 months – 
+ Solicitousness – Pain intensity at 12 months – 
+ Pain catastrophizing + GI symptom severity at 3 months + 
+ Pain catastrophizing + GI symptom severity at 6 months – 
+ Pain catastrophizing – GI symptom severity at 12 months – 
– Pain catastrophizing – Pain intensity at 3 months – 
– Pain catastrophizing + Pain intensity at 6 months – 
– Pain catastrophizing – Pain intensity at 12 months – 
Kashikar-
Zuck, et al. 
[33] 
CBT vs. fibromyalgia educa-
tion 
NR Pain coping NR Functional disability at 6 months – 
NR Pain coping NR Depression at 6 months – 
NR Pain catastrophizing NR Functional disability at 6 months – 
NR Pain catastrophizing NR Depression at 6 months – 
NR Coping efficacy NR Functional disability at 6 months – 
NR Coping efficacy NR Depression at 6 months – 
Wicksell, et 
al. [30] 
ACT vs. MDT + amitriptyline 
+ Pain impairment beliefs – Pain interference at 3.5 months – 
+ Pain impairment beliefs – Pain interference at 7 months – 
+ Pain impairment beliefs + Depression at 3.5 months + 
+ Pain impairment beliefs + Depression at 7 months + 
+ Pain reactivity + Pain interference at 3.5 months + 
+ Pain reactivity + Pain interference at 7 months + 
+ Pain reactivity + Depression at 3.5 months + 
– Pain reactivity + Depression at 7 months – 
– Self-efficacy – Pain interference at 3.5 months – 
– Self-efficacy – Pain interference at 7 months – 
– Self-efficacy – Depression at 3.5 months – 
– Self-efficacy – Depression at 7 months – 
– Kinesiophobia – Pain interference at 3.5 months –– 
– Kinesiophobia – Pain interference at 7 months – 
– Kinesiophobia – Depression at 3.5 months – 
– Kinesiophobia – Depression at 7 months – 
– Pain catastrophizing – Pain interference at 3.5 months – 
– Pain catastrophizing – Pain interference at 7 months – 
– Pain catastrophizing – Depression at 3.5 months – 
– Pain catastrophizing – Depression at 7 months – 
– Pain intensity – Pain interference at 3.5 months – 
– Pain intensity – Pain interference at 7 months – 
– Pain intensity – Depression at 3.5 months – 
– Pain intensity – Depression at 7 months – 
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Statistical significance is defined as 95% confidence intervals that do not contain zero. Mediation models with a statistically 
significant indirect effect are shaded in grey. (+): Statistically significant association; (−): Statistically non-significant asso-
ciation; (NR): Not reported; ACT, Acceptance and Commitment Therapy; CBT, Cognitive Behavioral Therapy; E, Expo-
sure; GI, Gastrointestinal; M, Mediator; MDT, Multidisciplinary therapy; O, Outcome; SLCBT, Social-Learning Cognitive 
Behavioral Therapy. 
4. Discussion 
There were several important findings from this review. First, the vast majority of 
analyses reveal variables that did not mediate treatment effect, but there is value in iden-
tifying mechanisms that do not explain why interventions work. Second, the mediators 
that were identified in this review suggest promising targets for interventions. Finally, 
there are meaningful opportunities to move the field forward by addressing methodolog-
ical and design considerations. 
The evidence in this review provides more guidance about mechanisms that do not 
explain why interventions for youth with pain work, rather than mechanisms that do. 
That is, 41 of the 53 models did not reveal mediators of treatment effect. While these find-
ings would need to be replicated in a larger number of methodologically-sound studies 
to increase validity, they provide preliminarily evidence that treatments for youth with 
pain may not operate via current theoretical explanations. For example, Kashikar-Zuck, 
et al. [33] found that neither pain catastrophizing, coping efficacy or pain coping mediated 
improvement in functioning or depressive symptoms following CBT. This indicates that 
CBT works through other undiscovered mechanisms and identifying such mechanisms 
would increase the ability to adapt CBT to improve its effectiveness in this population. 
However, identifying variables that do not mediate treatment effects does not necessarily 
mean that theoretical explanations for how treatments work are unsupported. Two stud-
ies in this review [30,32] assessed mediation models including variables that did not align 
with hypothesised theories of how interventions work, and other variables that did. For 
example, Wicksell, et al. [30] assessed six potential mediators for the effect of ACT on 
depression and pain interference. By demonstrated mediation effects in the variables that 
aligned with the hypothesised theory of ACT (i.e., pain impairment belief, pain reactivity), 
but not in the variables that did not (i.e., self-efficacy, kinesiophobia, pain catastrophizing, 
pain intensity), finding from this study support theoretical explanations for how ACT 
works. 
This review revealed mediators that may be promising targets of interventions for 
youth with pain. Two studies in this review assessed the outcome of GI-symptoms for 
children [29] or adolescents [32] with GI-related pain, revealing that GI- specific avoidance 
behaviour may be an important target of exposure-based internet CBT interventions. 
However, in other included studies, mediators were tested across different populations, 
types of pain, for different treatments and outcomes, making comparison difficult, and 
highlighting the limited state of the evidence. While mediation analyses in paediatric pain 
are common, research with designs able to identify mediators of interventions are rare. 
Longitudinal data are often used to conduct mediation analysis to investigate mechanisms 
of the development of symptoms (e.g. [40,41]), rather than mechanisms of interventions. 
When mediation analyses are used to investigate interventions, some studies use designs 
that limit the ability to conduct meaningful mediation analyses, such as longitudinal de-
signs without comparison groups (e.g. [42]). Ideally, mediation analyses would be embed-
ded into clinical trials, as a valuable tool to allow us to move beyond efficacy and investi-
gate how intervention for youth with pain do or do not work. More studies of this kind, 
for each type of intervention with consistent mediators and outcomes are needed to draw 
firm conclusions about specific mechanisms of interventions for youth with pain. 
4.1. Methodological Quality of Included Studies 
A key methodological strength of all studies in this review was the establishment of 
temporality, in that all mediators were measured prior to outcomes. Additionally, three 
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studies conducted sensitivity analyses to test the assumption of temporal precedence. 
Two studies [29,32] included models that assessed mediators at repeated time points—an 
approach that allows for investigating a treatment with a gradual change in the mediator 
and outcome [43]. However, methodological limitations were common. No studies esti-
mated a priori sample sizes for indirect or direct effects, which may reflect the complexi-
ties and lack of tools available for these calculations [44,45]. Despite their importance, less 
than half (21/53) of the mediation models in this review controlled for mediator-outcome 
confounders. Moreover, controlling for some confounders does not exclude the possibility 
of bias due to other, unmeasured confounders. Sensitivity analyses are recommended to 
assess the influence of unmeasured confounders [46], but they were not implemented in 
any study in this review. 
4.2. Future Recommendations 
In light of the methodological issues raised in this review, and the limited number of 
included studies, recommendations for future research are provided. 
4.2.1. Study Effective and Ineffective Interventions 
All included studies used mediation analysis to investigate mechanisms of effective 
interventions. However, there is also value in studying failed mechanisms of ineffective 
interventions. Mediation analysis of unsuccessful interventions can help identify where 
the hypothesized causal mechanisms break down. The results of such studies can then be 
used to reproduce or refine interventions. That is, if we identify mediators that have a 
causal effect on key outcomes (i.e., path b), but the intervention did not affect the mediator 
(i.e., path a), we may modify the intervention to specifically target the mediator. For ex-
ample, an RCT [47] revealed that a pain science education program was no more effective 
at reducing functional disability than usual care for adults with chronic back pain, and a 
secondary mediation analysis was conducted to answer why the intervention did not 
work [48]. The mediation analysis found that illness perceptions (intermediate variable) 
were significantly associated with functional disability (outcome), but the intervention 
did not significantly influence illness perceptions. The authors conclude that illness per-
ception may be an important target in future treatments. That no studies in this review 
investigated mechanisms of failed interventions is likely influenced by historical perspec-
tives on mediation whereby a statistically significant treatment effect was required to pro-
ceed with mediation analysis [20]. However, recent research has shown this requirement 
to be unnecessary, as indirect effects can be present in the absence of direct effects 
[13,38,49]. Therefore, mediation analysis of ineffective treatments is encouraged [10,50,51] 
and could benefit the paediatric pain field. 
4.2.2. Assess Shared Mechanisms Across Interventions 
Studying the same mediators across different interventions can help to identify if dif-
ferent treatments operate through shared mechanisms. Also, if shared mechanisms that 
affect multiple outcomes can be identified, then we can tailor interventions to specifically 
target those mechanisms [52]. For example, mechanistic research into treatments for 
adults with back pain suggest that different psychological interventions produce similar 
effects on outcomes through a common set of mediators (e.g., increased self-efficacy, re-
duced pain catastrophizing) [14,15]—the same may be true of interventions for youth with 
pain. In this review, it is difficult to draw conclusions on shared mechanisms as only two 
mediators (pain catastrophizing and GI-specific avoidance behaviour) were assessed 
across multiple studies. Of these, one study identified pain catastrophizing as a mediator 
of treatment effect [28], and two did not [30,33]; while both studies identified GI-specific 
avoidance behaviour as a mediator of treatment effect [29,32]. More mediation analyses 
in the field will provide better insight into the role of shared mechanisms. 
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4.3. Strengths and Limitations of This Review 
There are several strengths to this review, including preregistration (now recom-
mended practice in the pain field [53]), a comprehensive search strategy based on estab-
lished search terms, inclusion of a wide population of youth (aged 3 to 18) and use of two 
reviewers to independently screen and evaluate studies and extract data. Finally, a key 
strength of this review is the focus on formal mediation analyses with appropriate study 
designs (i.e., longitudinal designs with a comparison group), a choice that is reflected in 
our search terms. 
This review also has limitations. Study heterogeneity meant we were unable to com-
pare the magnitude of mediation effects across studies. Publication bias is also a possibil-
ity, but the limited number of included studies precluded formal evaluation of it. All but 
one study [33] in this review reported evidence in favour of one or more of the mediating 
pathways that were investigated. It is possible that post hoc mediation analyses were only 
conducted in studies that showed a significant treatment effect, and that primarily those 
with statistically significant results were published. It is also possible that our search strat-
egy biased towards selecting studies that reported mediation analysis in the title or ab-
stract, which may be more frequent when mediation analyses are significant. Finally, 
while we reported which studies conducted sample size calculations (none), we did not 
assess and exclude studies that were inadequately powered for mediation analysis. 
5. Conclusions 
This review identified six studies investigating 53 mediation models across a range 
of interventions for youth with pain. Across two studies, the literature on exposure-based 
internet CBT for youth with GI-specific chronic pain suggests that GI-avoidance behav-
iour may be an important mediators of treatment effect. However, comparison of mediat-
ing effects across other studies is limited by study heterogeneity. Investigating how treat-
ments for paediatric pain do, and do not work, is an emerging field. Improving the meth-
odological rigour of such investigations is important. Appropriate designs for mediation, 
emphasising causal assumptions such as confounding and assessing mechanisms of effec-
tive and ineffective interventions, should lead to stronger quality evidence for underlying 
causal mechanisms of interventions for paediatric pain, and ultimately more effective in-
terventions. 
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